ETrade Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,509	Closed	-$260K	–	736
2018 Q3	$260K	Buy	12,509 +623	+5%	+$12.9K	0.01%	733
2018 Q2	$181K	Buy	+11,886	New	+$181K	0.01%	763